These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35602011)

  • 21. Purification and biochemical characterization of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthases KasA and KasB.
    Schaeffer ML; Agnihotri G; Volker C; Kallender H; Brennan PJ; Lonsdale JT
    J Biol Chem; 2001 Dec; 276(50):47029-37. PubMed ID: 11600501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis.
    Veyron-Churlet R; Zanella-Cléon I; Cohen-Gonsaud M; Molle V; Kremer L
    J Biol Chem; 2010 Apr; 285(17):12714-25. PubMed ID: 20178986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Free enzyme dynamics of CmaA3 and CmaA2 cyclopropane mycolic acid synthases from Mycobacterium tuberculosis: Insights into residues with potential significance in cyclopropanation.
    Annaraj P D; Kadirvel P; Subramanian A; Anishetty S
    J Mol Graph Model; 2019 Sep; 91():61-71. PubMed ID: 31181453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
    Schroeder EK; de Souza N; Santos DS; Blanchard JS; Basso LA
    Curr Pharm Biotechnol; 2002 Sep; 3(3):197-225. PubMed ID: 12164478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.
    Slayden RA; Lee RE; Barry CE
    Mol Microbiol; 2000 Nov; 38(3):514-25. PubMed ID: 11069675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
    Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
    J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development.
    Bhatt A; Molle V; Besra GS; Jacobs WR; Kremer L
    Mol Microbiol; 2007 Jun; 64(6):1442-54. PubMed ID: 17555433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.
    Kurth DG; Gago GM; de la Iglesia A; Bazet Lyonnet B; Lin TW; Morbidoni HR; Tsai SC; Gramajo H
    Microbiology (Reading); 2009 Aug; 155(Pt 8):2664-2675. PubMed ID: 19423629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Identification of alkaloid compounds as potent inhibitors of Mycobacterium tuberculosis NadD using computational strategies".
    Verma AK; Dubey S; Srivastava SK
    Comput Biol Med; 2023 May; 158():106863. PubMed ID: 37030267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis and Biological Evaluation of Some Triazole Schiff's Base Derivatives as Potential Antitubercular Agents.
    Sager AA; Abood ZS; El-Amary WM; Bensaber SM; Al-Sadawe IA; Ermeli NB; Mohamed SB; Al-Forgany M; Mrema IA; Erhuma M; Hermann A; Gbaj AM
    Open Med Chem J; 2018; 12():48-59. PubMed ID: 29854013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
    Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
    Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach.
    Sharma A; Islam MH; Fatima N; Upadhyay TK; Khan MKA; Dwivedi UN; Sharma R
    Mol Biol Rep; 2019 Apr; 46(2):1715-1725. PubMed ID: 30715689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
    Alsayed SSR; Beh CC; Foster NR; Payne AD; Yu Y; Gunosewoyo H
    Curr Mol Pharmacol; 2019; 12(1):27-49. PubMed ID: 30360731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening to identify novel potential inhibitors for Glutamine synthetase of
    Kumari M; Subbarao N
    J Biomol Struct Dyn; 2020 Oct; 38(17):5062-5080. PubMed ID: 31755360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The β-ketoacyl-ACP synthase from Mycobacterium tuberculosis as potential drug targets.
    Singh V; Mani I; Chaudhary DK; Somvanshi P
    Curr Med Chem; 2011; 18(9):1318-24. PubMed ID: 21370994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability.
    Veyron-Churlet R; Guerrini O; Mourey L; Daffé M; Zerbib D
    Mol Microbiol; 2004 Dec; 54(5):1161-72. PubMed ID: 15554959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AcpM, the meromycolate extension acyl carrier protein of Mycobacterium tuberculosis, is activated by the 4'-phosphopantetheinyl transferase PptT, a potential target of the multistep mycolic acid biosynthesis.
    Zimhony O; Schwarz A; Raitses-Gurevich M; Peleg Y; Dym O; Albeck S; Burstein Y; Shakked Z
    Biochemistry; 2015 Apr; 54(14):2360-71. PubMed ID: 25785780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4
    Venugopala KN; Kandeel M; Pillay M; Deb PK; Abdallah HH; Mahomoodally MF; Chopra D
    Antibiotics (Basel); 2020 Aug; 9(9):. PubMed ID: 32878018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Silico Drug Repurposing Approach: Investigation of
    Ngidi NTP; Machaba KE; Mhlongo NN
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.